HomeTYRA • NASDAQ
add
Tyra Biosciences Inc
Previous close
$9.86
Day range
$9.82 - $10.64
Year range
$6.42 - $29.60
Market cap
531.25M USD
Avg Volume
331.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 31.85M | 42.68% |
Net income | -28.15M | -54.72% |
Net profit margin | — | — |
Earnings per share | -0.47 | -34.29% |
EBITDA | -31.71M | -42.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 318.94M | -16.61% |
Total assets | 343.48M | -15.14% |
Total liabilities | 19.94M | 34.18% |
Total equity | 323.53M | — |
Shares outstanding | 53.18M | — |
Price to book | 1.62 | — |
Return on assets | -22.52% | — |
Return on capital | -23.45% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -28.15M | -54.72% |
Cash from operations | -25.46M | -15.57% |
Cash from investing | 32.03M | 77.20% |
Cash from financing | 2.19M | -98.91% |
Net change in cash | 8.76M | -95.54% |
Free cash flow | -13.32M | 20.11% |
About
Founded
2018
Headquarters
Website
Employees
60
